|
JP2020196738A
|
|
Hyaluronic acid production promoter
|
|
WO2019244934A1
|
|
Novel anti-pad2 antibody
|
|
JP2020132538A
|
|
Expression enhancers for sirtuin gene and agents for normalizing cell cycle
|
|
JP2019004878A
|
|
Composition having improved stability of biologically active material with low stability
|
|
JP2019085380A
|
|
Hyaluronic acid production promoter
|
|
WO2018025869A1
|
|
Biomarker for predicting therapeutic effect of fstl1 inhibitor in cancer patient
|
|
US2020316161A1
|
|
Preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases
|
|
WO2016133059A1
|
|
Anti-cancer agent and antimetastatic agent using fstl1, and concomitant drug for same
|
|
WO2016129174A1
|
|
Hyaluronic acid production promoter
|
|
WO2016068338A1
|
|
Hair growth promoter and use therefor
|
|
US2016362466A1
|
|
Peptides having osteoblast growth-promoting activity and use thereof
|
|
JP2015028008A
|
|
Protein-containing spray, and long-term protein storage method
|
|
JP2015159806A
|
|
Banana enzyme-treated product and its utilization
|
|
JP2015063499A
|
|
Polyclonal antibody which has bitter taste receptor t2r activating action
|
|
CN104736164A
|
|
Cartilage cell growth promoter
|
|
JP2014005195A
|
|
Calcium-containing composition
|
|
JP2014040402A
|
|
Hyaluronic acid production accelerating agent
|
|
JP2014001163A
|
|
No production promoting composition and poor circulation improver containing the same
|
|
JP2013040115A
|
|
Egg shell membrane powder having lysyl oxidase activity
|
|
JP2012180393A
|
|
Peroxy radical-eliminating agent
|
